Community-acquired pneumonia. Current treatment regimens in pediatric practice

At the moment, an increase in the incidence of community-acquired pneumonia is quite an urgent problem. Its solution is based on the use of adequate antibacterial therapy, which will help significantly reduce the spread of the disease among children included in the risk group.
 Goal: Conducting a comprehensive assessment of etiological therapy tactics for community-acquired bacterial pneumonia in children and determining their compliance with modern clinical recommendations.
 Materials and methods: The study was conducted on the basis of the Voronezh Childrens Clinical Hospital of the Voronezh State Medical University named after N.N. Burdenko. A retrospective analysis of 18 case histories of patients aged 3 to 14 years who were treated from October 2021 to March 2022 with a diagnosis of community-acquired pneumonia of moderate severity was carried out.
 Results: During the analysis of the medical histories of children diagnosed with community-acquired pneumonia, it was found that the diagnosis of the patients condition was complete and sufficient in each of the cases considered, with the exception of the absence of sputum in terms of bacteriological examination, because the treatment was more empirical in nature, directed against the frequently detected pathogen determining the formation of this nosological form S. rpeimopiae.
 Conclusion: As a result of a comprehensive assessment of the tactics of etiological therapy of community-acquired bacterial pneumonia in children, it was revealed that effective antibiotic therapy was chosen for all patients in accordance with the severity of the disease and instructions for the use of antibacterial drugs, which led to the gradual elimination of clinical symptoms of community-acquired pneumonia.